Teva Pharmaceuticals (NYSE:TEVA) said this week that CEO Erez Vigodman has stepped down from their position at the head of the world’s biggest generic drugmaker. Vigodman’s exit from the company will take effect immediately, with board chair Yitzhak Peterburg taking on the interim role of chief exec. Israel-based Teva has seen shares plummet after a series of […]
Stereotaxis
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest surgical robot players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find […]
Stereotaxis raises $24m
Medical robotics developer Stereotaxis (NSDQ:STXS) said yesterday it closed a $24 million private placement round, floating 24,000 shares of convertible preferred stock and warrants for the purchase of an aggregate 36.9 million shares of common stock. Each preferred share sold in the round is convertible at the option of the holder at a price of 65¢ per […]
Analyst: Medtronic most likely to challenge Intuitive Surgical in robot-assisted surgery
Medtronic (NYSE:MDT) is the most likely rival to Intuitive Surgical‘s (NSDQ:ISRG) dominance in the robot-assisted surgery space, but is still at least a year away from putting a competing device on the market, according to 1 analyst covering the medical device industry. Sunnyvale, Calif.-based Intuitive has a long lead, having had its flagship da Vinci system since 2000 and is […]
TAVI: Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves
Press Release: Stereotaxis receives FDA clearance of Vdrive with V-Loop system
Stereotaxis touts FDA win for robotic platform’s catheter manipulator
Missouri-based Stereotaxis (NSDQ:STXS) announced FDA clearance for its V-Loop product, the 2nd model from its Vdrive platform to make it to the U.S. market.
Stereotaxis escapes all shareholder lawsuits
Surgical robotics maker Stereotaxis (NSDQ:STXS) announced week that it’s officially clear of all shareholder litigation after a pair of lawsuits quietly closed this year.
Zimmer executive takes top job at Smiths Medical | Personnel Moves
Smiths Medical president Srini Seshadri is expected to step down, and Zimmer (NYSE:ZMH) executive Jeff McCaulley will step into the top office.
There was no reason given for Seshadri’s departure. He joined the company in 2006 and helped navigate some tough times when it was under-performing, Smiths said.
Rights offering raises $10M for Stereotaxis
Stereotaxis (NSDQ:STXS) said today that a subscription rights offering brought in about $10.2 million in gross proceeds.
A subscription rights offering allows existing shareholders to acquire stock in a company, usually at a discount.
Stereotaxis jumps on Japanese reimbursement win, releases Q3 prelims
Stereotaxis won Japan’s highest reimbursement classification for its Niobe magnetic navigation system.
The Niobe system is now classified as a C2 medical device by Japan’s Ministry of Health, Labor & Welfare, according to a press release.
